NCT00745563

Brief Summary

A couple that does not achieve pregnancy though regular attempts for a year are defined infertile couple. This condition is caused by faulty functioning of the reproduction system of the husband or wife or both. If there are no organic defects and there is no definite injury to the reproductive system (ova or spermatozoa), the specialist doctor generally decides to put the couple into a fertility treatment program. Artificial insemination is one of the important ways of achieving pregnancy. Three common methods of artificial insemination:

  • Very close approximation of the natural procedure in which the spermatozoa arrive to the fertilization site over a long period.
  • An extended "window of opportunities" for meeting between the ovum and spermatozoa will be longer.
  • There is no loss of spermatozoa due to leaking as sometimes happens with single-time injection practiced in the IUI method. Primary Endpoint: Accumulation of 50 cycles of SRI- slow release insemination (study group) in addition to 50 cycles of regular IUI (control group). Two weeks after insemination Beta hCG test Secondary Endpoints: Four weeks after insemination - US Viability scan Procedure: Subjects will be women with fertility difficulties who are designated for IUI treatment. 100 insemination cycles will be conducted. (50 regular IUI and 50 EVIE-SRI). Subjects that were treated with the IUI method and who does not become pregnant will then be treated with the EVIE-Slow Release method and vice versa.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 3, 2008

Completed
28 days until next milestone

Study Start

First participant enrolled

October 1, 2008

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
Last Updated

June 9, 2011

Status Verified

December 1, 2008

Enrollment Period

8 months

First QC Date

August 30, 2008

Last Update Submit

June 8, 2011

Conditions

Keywords

infertilityinseminationslow release

Outcome Measures

Primary Outcomes (1)

  • Accumulation of 50 cycles of SRI- slow release insemination (study group) in addition to 50 cycles of regular IUI (control group). Two weeks after insemination Beta hCG test

    2 weeks following procedure

Secondary Outcomes (1)

  • Four weeks after insemination - US Viability scan

    4 weeks following procedure

Study Arms (1)

A

EXPERIMENTAL
Device: Fertiligent

Interventions

Fertility treatment by using the EVIE - Slow Release Insemination method

A

Eligibility Criteria

Age20 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Primary or secondary infertility designated for IUI treatment.
  • Age of candidates: 20-40 years.
  • Normal uterus x-ray.
  • Women suffering from infertility on a background of non-ovulation.
  • Infertility on a background of male problems (over 10 million of motile sperm cells per sample).
  • Infertility on background of unexplained problem
  • Same sex patients / single patient
  • Written informed consent

You may not qualify if:

  • Woman under the age of 20 or over the age of 40 years.
  • Female infertility on mechanical background (different blockages, irregular uterus).
  • Infertility on male background of medium to very low level of spermatozoa - less than 10 million motile sperm cells per sample.
  • Men and women who are opposed to the random spermatozoa insemination method.
  • Participants who are not willing to sign the Consent Form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, 31048, Israel

Location

MeSH Terms

Conditions

Infertility

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Study Officials

  • Martha Dirnfeld, Prof.

    Carmel medical Center, Haifa Israel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 30, 2008

First Posted

September 3, 2008

Study Start

October 1, 2008

Primary Completion

June 1, 2009

Study Completion

December 1, 2009

Last Updated

June 9, 2011

Record last verified: 2008-12

Locations